[Sclerosing treatment of esophageal varices].
Sixty-five patients with hepatic cirrhosis and esophageal varices were subjected to endoscopic sclerotherapy. Twelve patients were treated in the intervals between hemorrhages; 43 patients were treated after their first hemorrhage. The rate of survival in a 5 to 26 month period was 82%.
D004932:Esophageal and Gastric Varices / Q000150:complications / Q000628:therapy*; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D007263:Infusions, Parenteral; D008103:Liver Cirrhosis / Q000150:complications; D011379:Prognosis; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use*
D012597:Sclerosing Solutions
Tratamiento esclerosante de las várices esofágicas.